These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 11784713

  • 1. Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells.
    Lee TH, Avraham H, Lee SH, Avraham S.
    J Biol Chem; 2002 Mar 22; 277(12):10445-51. PubMed ID: 11784713
    [Abstract] [Full Text] [Related]

  • 2. Vascular endothelial growth factor modulates the transendothelial migration of MDA-MB-231 breast cancer cells through regulation of brain microvascular endothelial cell permeability.
    Lee TH, Avraham HK, Jiang S, Avraham S.
    J Biol Chem; 2003 Feb 14; 278(7):5277-84. PubMed ID: 12446667
    [Abstract] [Full Text] [Related]

  • 3. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: In vivo neovascularization induced by stromal-derived factor-1alpha.
    Salcedo R, Wasserman K, Young HA, Grimm MC, Howard OM, Anver MR, Kleinman HK, Murphy WJ, Oppenheim JJ.
    Am J Pathol; 1999 Apr 14; 154(4):1125-35. PubMed ID: 10233851
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells.
    Pupilli C, Lasagni L, Romagnani P, Bellini F, Mannelli M, Misciglia N, Mavilia C, Vellei U, Villari D, Serio M.
    J Am Soc Nephrol; 1999 Feb 14; 10(2):245-55. PubMed ID: 10215323
    [Abstract] [Full Text] [Related]

  • 5. Down-modulation of monocyte transendothelial migration and endothelial adhesion molecule expression by fibroblast growth factor: reversal by the anti-angiogenic agent SU6668.
    Zhang H, Issekutz AC.
    Am J Pathol; 2002 Jun 14; 160(6):2219-30. PubMed ID: 12057924
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-1 beta upregulates cardiac expression of vascular endothelial growth factor and its receptor KDR/flk-1 via activation of protein tyrosine kinases.
    Maruyama K, Mori Y, Murasawa S, Masaki H, Takahashi N, Tsutusmi Y, Moriguchi Y, Shibazaki Y, Tanaka Y, Shibuya M, Inada M, Matsubara H, Iwasaka T.
    J Mol Cell Cardiol; 1999 Mar 14; 31(3):607-17. PubMed ID: 10198191
    [Abstract] [Full Text] [Related]

  • 7. Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression.
    Brogi E, Schatteman G, Wu T, Kim EA, Varticovski L, Keyt B, Isner JM.
    J Clin Invest; 1996 Jan 15; 97(2):469-76. PubMed ID: 8567969
    [Abstract] [Full Text] [Related]

  • 8. Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin.
    Detmar M, Brown LF, Berse B, Jackman RW, Elicker BM, Dvorak HF, Claffey KP.
    J Invest Dermatol; 1997 Mar 15; 108(3):263-8. PubMed ID: 9036922
    [Abstract] [Full Text] [Related]

  • 9. Vascular endothelial growth factor regulates focal adhesion assembly in human brain microvascular endothelial cells through activation of the focal adhesion kinase and related adhesion focal tyrosine kinase.
    Avraham HK, Lee TH, Koh Y, Kim TA, Jiang S, Sussman M, Samarel AM, Avraham S.
    J Biol Chem; 2003 Sep 19; 278(38):36661-8. PubMed ID: 12844492
    [Abstract] [Full Text] [Related]

  • 10. Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells.
    Marumo T, Schini-Kerth VB, Busse R.
    Diabetes; 1999 May 19; 48(5):1131-7. PubMed ID: 10331420
    [Abstract] [Full Text] [Related]

  • 11. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin.
    Senger DR, Ledbetter SR, Claffey KP, Papadopoulos-Sergiou A, Peruzzi CA, Detmar M.
    Am J Pathol; 1996 Jul 19; 149(1):293-305. PubMed ID: 8686754
    [Abstract] [Full Text] [Related]

  • 12. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin.
    Murohara T, Horowitz JR, Silver M, Tsurumi Y, Chen D, Sullivan A, Isner JM.
    Circulation; 1996 Jul 19; 97(1):99-107. PubMed ID: 9443437
    [Abstract] [Full Text] [Related]

  • 13. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells.
    Detmar M, Yeo KT, Nagy JA, Van de Water L, Brown LF, Berse B, Elicker BM, Ledbetter S, Dvorak HF.
    J Invest Dermatol; 1995 Jul 19; 105(1):44-50. PubMed ID: 7615975
    [Abstract] [Full Text] [Related]

  • 14. Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes.
    Gille J, Khalik M, König V, Kaufmann R.
    J Invest Dermatol; 1998 Dec 19; 111(6):1160-5. PubMed ID: 9856833
    [Abstract] [Full Text] [Related]

  • 15. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines.
    Bancroft CC, Chen Z, Yeh J, Sunwoo JB, Yeh NT, Jackson S, Jackson C, Van Waes C.
    Int J Cancer; 2002 Jun 01; 99(4):538-48. PubMed ID: 11992543
    [Abstract] [Full Text] [Related]

  • 16. Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription.
    Reisinger K, Kaufmann R, Gille J.
    J Cell Sci; 2003 Jan 15; 116(Pt 2):225-38. PubMed ID: 12482909
    [Abstract] [Full Text] [Related]

  • 17. Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes.
    Shen H, Clauss M, Ryan J, Schmidt AM, Tijburg P, Borden L, Connolly D, Stern D, Kao J.
    Blood; 1993 May 15; 81(10):2767-73. PubMed ID: 8490183
    [Abstract] [Full Text] [Related]

  • 18. Vascular permeability factor/vascular endothelial growth factor-mediated signaling in mouse mesentery vascular endothelium.
    Mukhopadhyay D, Nagy JA, Manseau EJ, Dvorak HF.
    Cancer Res; 1998 Mar 15; 58(6):1278-84. PubMed ID: 9515816
    [Abstract] [Full Text] [Related]

  • 19. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
    Yano S, Herbst RS, Shinohara H, Knighton B, Bucana CD, Killion JJ, Wood J, Fidler IJ.
    Clin Cancer Res; 2000 Mar 15; 6(3):957-65. PubMed ID: 10741721
    [Abstract] [Full Text] [Related]

  • 20. Heterotrimeric G alpha q/G alpha 11 proteins function upstream of vascular endothelial growth factor (VEGF) receptor-2 (KDR) phosphorylation in vascular permeability factor/VEGF signaling.
    Zeng H, Zhao D, Yang S, Datta K, Mukhopadhyay D.
    J Biol Chem; 2003 Jun 06; 278(23):20738-45. PubMed ID: 12670961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.